Invirion Diagnostics

Invirion Diagnostics is a biotechnology company specializing in the development of rapid, high-sensitivity diagnostic platforms for infectious diseases. The company's core technology, the Invirion platform, utilizes a proprietary electrochemical biosensor to detect whole virus particles directly from clinical samples, eliminating the need for time-consuming sample preparation or nucleic acid amplification. This approach allows for PCR-level sensitivity with the speed of an antigen test, providing results in minutes. Initially focused on SARS-CoV-2, the company is expanding its pipeline to include other respiratory pathogens and point-of-care applications. The technology is designed to be modular, allowing for the rapid development of tests for emerging viral threats.